Cancer/testis antigen PAGE4, a regulator of c-jun transactivation, is phosphorylated by homeodomain-interacting protein kinase 1, a component of the stress-response pathway

Biochemistry

Volumn 53, Issue 10, 2014, Pages 1670-1679

  Mooney, Steven M ^a   Qiu, Ruoyi ^b   Kim, John J ^a   Sacho, Elizabeth J ^b   Rajagopalan, Krithika ^c   Johng, Dorhyun ^a   Shiraishi, Takumi ^a   Kulkarni, Prakash ^a,d   Weninger, Keith R ^a,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c University of California   (United States)

^d Columbia University ^*  (United States)

^e UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; ANTIGENS; DISEASES; ENZYMES; TRANSCRIPTION; UROLOGY;

CELLULAR STRESS; CONFORMATIONAL CHANGE; EXPRESSION PATTERNS; PROSTATE GLANDS; SINGLE-MOLECULE FRETS; STRESS RESPONSE; STRESS RESPONSE PROTEINS; TRANSCRIPTIONAL ACTIVITY;

PHOSPHORYLATION;

CANCER TESTIS ANTIGEN; HOMEODOMAIN INTERACTING PROTEIN KINASE 1; PROSTATE ASSOCIATED GENE 4 ANTIGEN; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CONFORMATIONAL TRANSITION; ENZYME ACTIVITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSACTIVATION;

AMINO ACID MOTIFS; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; HUMANS; MALE; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TESTIS; TRANSCRIPTIONAL ACTIVATION;

EID: 84898951521     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi500013w     Document Type: Article

References (74)

1. Rajagopalan, K. et al. (2014) Biochim, Biophys. Acta 1842, 154-163
2. Rajagopalan, K., Qiu, R., Mooney, S. M., Rao, S., Shiraishi, T., Sacho, E., Huang, H., Shapiro, E., Weninger, K. R., and Kulkarni, P. (2014) The Stress-response protein prostate-associated gene 4, interacts with c-Jun and potentiates its transactivation Biochim. Biophys. Acta 1842, 154-163
3. Scanlan, M. J., Gure, A. O., Jungbluth, A. A., Old, L. J., and Chen, Y. T. (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy Immunol. Rev. 188, 22-32
4. Simpson, A. J., Caballero, O. L., Jungbluth, A., Chen, Y. T., and Old, L. J. (2005) Cancer/testis antigens, gametogenesis and cancer Nat. Rev. Cancer 5, 615-625
5. Stevenson, B. J., Iseli, C., Panji, S., Zahn-Zabal, M., Hide, W., Old, L. J., Simpson, A. J., and Jongeneel, C. V. (2007) Rapid evolution of cancer/testis genes on the X chromosome BMC Genomics 8, 129
6. Dobrynin, P., Matyunina, E., Malov, S. V., and Kozlov, A. P. (2013) The novelty of human cancer/testis antigen encoding genes in evolution Int. J. Genomics 2013, 105108
7. Kulkarni, P., Shiraishi, T., Rajagopalan, K., Kim, R., Mooney, S. M., and Getzenberg, R. H. (2012) Cancer/testis antigens and urological malignancies Nat. Rev. Urol. 9, 386-396
8. Marcar, L., Maclaine, N. J., Hupp, T. R., and Meek, D. W. (2010) Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin Cancer Res. 70, 10362-10370
9. Zeng, Y., He, Y., Yang, F., Mooney, S. M., Getzenberg, R. H., Orban, J., and Kulkarni, P. (2011) The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein J. Biol. Chem. 286, 13985-13994
10. Sharma, A., Bode, B., Wenger, R. H., Lehmann, K., Sartori, A. A., Moch, H., Knuth, A., Boehmer, L., and Broek, M. (2011) gamma-Radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo PLoS One 6, e28217
11. Wang, J., Wang, H., Hou, W., Liu, H., Zou, Y., Zhang, H., Hou, L., McNutt, M. A., and Zhang, B. (2013) Subnuclear distribution of SSX regulates its function Mol. Cell. Biochem. 381, 17-29
12. Rajagopalan, K., Mooney, S. M., Parekh, N., Getzenberg, R. H., and Kulkarni, P. (2011) A majority of the cancer/testis antigens are intrinsically disordered proteins J. Cell. Biochem. 112, 3256-3267
13. Uversky, V. N. (2010) The mysterious unfoldome: Structureless, underappreciated, yet vital part of any given proteome J. Biomed. Biotechnol. 2010, 568068
14. Tompa, P. (2012) Intrinsically disordered proteins: a 10-year recap Trends Biochem. Sci. 37, 509-516
15. Uversky, V. N., Oldfield, C. J., and Dunker, A. K. (2008) Intrinsically disordered proteins in human diseases: introducing the D2 concept Annu. Rev. Biophys. 37, 215-246
16. Patil, A., Kinoshita, K., and Nakamura, H. (2010) Hub promiscuity in protein-protein interaction networks Int. J. Mol. Sci. 11, 1930-1943
17. Haynes, C., Oldfield, C. J., Ji, F., Klitgord, N., Cusick, M. E., Radivojac, P., Uversky, V. N., Vidal, M., and Iakoucheva, L. M. (2006) Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes PLoS Comput. Biol. 2, e100
18. Tompa, P. and Csermely, P. (2004) The role of structural disorder in the function of RNA and protein chaperones FASEB J. 18, 1169-1175
19. Edwards, Y. J., Lobley, A. E., Pentony, M. M., and Jones, D. T. (2009) Insights into the regulation of intrinsically disordered proteins in the human proteome by analyzing sequence and gene expression data Genome Biol. 10, R50
20. Babu, M. M., van der Lee, R., de Groot, N. S., and Gsponer, J. (2011) Intrinsically disordered proteins: regulation and disease Curr. Opin. Struct. Biol. 21, 432-440
21. Prakash, K., Pirozzi, G., Elashoff, M., Munger, W., Waga, I., Dhir, R., Kakehi, Y., and Getzenberg, R. H. (2002) Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays Proc. Natl. Acad. Sci. U.S.A. 99, 7598-7603
22. Bull, J. H., Ellison, G., Patel, A., Muir, G., Walker, M., Underwood, M., Khan, F., and Paskins, L. (2001) Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray Br. J. Cancer 84, 1512-1519
23. Iavarone, C., Wolfgang, C., Kumar, V., Duray, P., Willingham, M., Pastan, I., and Bera, T. K. (2002) PAGE4 is a cytoplasmic protein that is expressed in normal prostate and in prostate cancers Mol. Cancer Ther. 1, 329-335
24. Sampson, N., Untergasser, G., Lilg, C., Tadic, L., Plas, E., and Berger, P. (2007) GAGEC1, a cancer/testis associated antigen family member, is a target of TGF-beta1 in age-related prostatic disease Mech. Ageing Dev. 128, 64-66
25. Suyama, T., Shiraishi, T., Zeng, Y., Yu, W., Parekh, N., Vessella, R. L., Luo, J., Getzenberg, R. H., and Kulkarni, P. (2010) Expression of cancer/testis antigens in prostate cancer is associated with disease progression Prostate (Hoboken, NJ, U.S.) 70, 1778-1787
26. Zeng, Y. G. D., Kim, J. J., Shiraishi, T., Terada, N., Kakehi, Y., Kong, C., Getzenberg, R. H., and Kulkarni, P. (2013) Prostate-associated gene 4 (PAGE4) protects cells against stress by elevating p21 and suppressing reactive oxygen species production Am. J. Clin. Exp. Urol. 1, 39-52
27. Sampson, N., Ruiz, C., Zenzmaier, C., Bubendorf, L., and Berger, P. (2012) PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer Am. J. Pathol. 181, 1443-1454
28. Sato, N., Sadar, M. D., Bruchovsky, N., Saatcioglu, F., Rennie, P. S., Sato, S., Lange, P. H., and Gleave, M. E. (1997) Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP J. Biol. Chem. 272, 17485-17494
29. Edwards, J., Krishna, N. S., Mukherjee, R., and Bartlett, J. M. (2004) The role of c-Jun and c-Fos expression in androgen-independent prostate cancer J. Pathol. 204, 153-158
30. Chen, S. Y., Cai, C., Fisher, C. J., Zheng, Z., Omwancha, J., Hsieh, C. L., and Shemshedini, L. (2006) c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation Oncogene 25, 7212-7223
31. Cai, C., Hsieh, C. L., and Shemshedini, L. (2007) c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer Mol. Cancer Res. 5, 725-735
32. Li, W., Wu, C. L., Febbo, P. G., and Olumi, A. F. (2007) Stromally expressed c-Jun regulates proliferation of prostate epithelial cells Am. J. Pathol. 171, 1189-1198
33. Sun, T., Yang, M., Chen, S., Balk, S., Pomerantz, M., Hsieh, C. L., Brown, M., Lee, G. S., and Kantoff, P. W. (2012) The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer Prostate (Hoboken, NJ, U.S.) 72, 1093-1103
34. Leppa, S. and Bohmann, D. (1999) Diverse functions of JNK signaling and c-Jun in stress response and apoptosis Oncogene 18, 6158-6162
35. Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Derijard, B., and Davis, R. J. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors EMBO J. 15, 2760-2770
36. Parra, E. (2012) Inhibition of JNK-1 by small interfering RNA induces apoptotic signaling in PC-3 prostate cancer cells Int. J. Mol. Med. 30, 923-930
37. Galardi, S., Mercatelli, N., Farace, M. G., and Ciafre, S. A. (2011) NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells Nucleic Acids Res. 39, 3892-3902
38. Yang, Y. M., Bost, F., Charbono, W., Dean, N., McKay, R., Rhim, J. S., Depatie, C., and Mercola, D. (2003) C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma Clin. Cancer Res. 9, 391-401
39. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B. E., Karandikar, M., Berman, K., and Cobb, M. H. (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions Endocr. Rev. 22, 153-183
40. Choi, U. B., Weninger, K. R., and Bowen, M. E. (2012) Immobilization of proteins for single-molecule fluorescence resonance energy transfer measurements of conformation and dynamics Methods Mol. Biol. 896, 3-20
41. Choi, U. B., McCann, J. J., Weninger, K. R., and Bowen, M. E. (2011) Beyond the random coil: stochastic conformational switching in intrinsically disordered proteins Structure 19, 566-576
42. Li, Y., Augustine, G. J., and Weninger, K. (2007) Kinetics of complexin binding to the SNARE complex: correcting single molecule FRET measurements for hidden events Biophys. J. 93, 2178-2187
43. McCann, J. J., Choi, U. B., Zheng, L., Weninger, K., and Bowen, M. E. (2010) Optimizing methods to recover absolute FRET efficiency from immobilized single molecules Biophys. J. 99, 961-970
44. Luo, J., Duggan, D. J., Chen, Y., Sauvageot, J., Ewing, C. M., Bittner, M. L., Trent, J. M., and Isaacs, W. B. (2001) Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling Cancer Res. 61, 4683-4688
45. Bova, G. S., Fox, W. M., and Epstein, J. I. (1993) Methods of radical prostatectomy specimen processing: a novel technique for harvesting fresh prostate cancer tissue and review of processing techniques Mod. Pathol. 6, 201-207
46. Suzuki, H., Freije, D., Nusskern, D. R., Okami, K., Cairns, P., Sidransky, D., Isaacs, W. B., and Bova, G. S. (1998) Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues Cancer Res. 58, 204-209
47. Hu, R., Dunn, T. A., Wei, S., Isharwal, S., Veltri, R. W., Humphreys, E., Han, M., Partin, A. W., Vessella, R. L., Isaacs, W. B., Bova, G. S., and Luo, J. (2009) Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer Cancer Res. 69, 16-22
48. Terada, N., Shiraishi, T., Zeng, Y., Mooney, S. M., Yeater, D. B., Mangold, L. A., Partin, A. W., Kulkarni, P., and Getzenberg, R. H. (2012) Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness Prostate 72, 966-976
49. Shiraishi, T., Terada, N., Zeng, Y., Suyama, T., Luo, J., Trock, B., Kulkarni, P., and Getzenberg, R. H. (2011) Cancer/Testis Antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy J. Transl. Med. 9, 153
50. Kim, J. J., Rajagopalan, K., Hussain, B., Williams, B. H., Kulkarni, P., and Mooney, S. M. (2013) CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers Biomarker Res. 1, 22
51. Gsponer, J., Futschik, M. E., Teichmann, S. A., and Babu, M. M. (2008) Tight regulation of unstructured proteins: from transcript synthesis to protein degradation Science 322, 1365-1368
52. Iakoucheva, L. M., Radivojac, P., Brown, C. J., OConnor, T. R., Sikes, J. G., Obradovic, Z., and Dunker, A. K. (2004) The importance of intrinsic disorder for protein phosphorylation Nucleic Acids Res. 32, 1037-1049
53. Nishi, H., Fong, J. H., Chang, C., Teichmann, S. A., and Panchenko, A. R. (2013) Regulation of protein-protein binding by coupling between phosphorylation and intrinsic disorder: analysis of human protein complexes Mol. Biosyst. 9, 1620-1626
54. Tompa, P. and Csermely, P. (2004) The role of structural disorder in the function of RNA and protein chaperones FASEB J. 18, 1169-1175
55. Fink, A. L. (2005) Natively unfolded proteins Curr. Opin. Struct. Biol. 15, 35-41
56. Choi, U. B., Kazi, R., Stenzoski, N., Wollmuth, L. P., Uversky, V. N., and Bowen, M. E. (2013) Modulating the intrinsic disorder in the cytoplasmic domain alters the biological activity of the N-methyl-D-aspartate-sensitive glutamate receptor J. Biol. Chem. 288, 22506-22515
57. Choi, U. B., Xiao, S., Wollmuth, L. P., and Bowen, M. E. (2011) Effect of Src kinase phosphorylation on disordered C-terminal domain of N-methyl-D-aspartic acid (NMDA) receptor subunit GluN2B protein J. Biol. Chem. 286, 29904-29912
58. Bondos, S. E. and Hsiao, H. C. (2012) Roles for intrinsic disorder and fuzziness in generating context-specific function in Ultrabithorax, a Hox transcription factor Adv. Exp. Med. Biol. 725, 86-105
59. Fong, J. H., Shoemaker, B. A., Garbuzynskiy, S. O., Lobanov, M. Y., Galzitskaya, O. V., and Panchenko, A. R. (2009) Intrinsic disorder in protein interactions: insights from a comprehensive structural analysis PLoS Comput. Biol. 5, e1000316
60. Chong, P. A., Ozdamar, B., Wrana, J. L., and Forman-Kay, J. D. (2004) Disorder in a target for the smad2 mad homology 2 domain and its implications for binding and specificity J. Biol. Chem. 279, 40707-40714
61. Chakrabortee, S., Meersman, F., Kaminski Schierle, G. S., Bertoncini, C. W., McGee, B., Kaminski, C. F., and Tunnacliffe, A. (2010) Catalytic and chaperone-like functions in an intrinsically disordered protein associated with desiccation tolerance Proc. Natl. Acad. Sci. U.S.A. 107, 16084-16089
62. Mitrea, D. M. and Kriwacki, R. W. (2012) Cryptic disorder: an order-disorder transformation regulates the function of nucleophosmin Pac. Symp. Biocomput. 152-163
63. Fenton, A. W. (2013) Are all regions of folded proteins that undergo ligand-dependent order-disorder transitions targets for allosteric peptide mimetics? Biopolymers 100, 553-557
64. Babu, M. M., Kriwacki, R. W., and Pappu, R. V. (2012) Structural biology. Versatility from protein disorder Science 337, 1460-1461
65. Johnson, L. N. and Lewis, R. J. (2001) Structural basis for control by phosphorylation Chem. Rev. 101, 2209-2242
66. Radhakrishnan, I., Perez-Alvarado, G. C., Parker, D., Dyson, H. J., Montminy, M. R., and Wright, P. E. (1997) Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions Cell 91, 741-752
67. Huang, K. L., Chadee, A. B., Chen, C. Y., Zhang, Y., and Shyu, A. B. (2013) Phosphorylation at intrinsically disordered regions of PAM2 motif-containing proteins modulates their interactions with PABPC1 and influences mRNA fate RNA 19, 295-305
68. Kosol, S., Contreras-Martos, S., Cedeǹo, C., and Tompa, P. (2013) Structural characterization of intrinsically disordered proteins by NMR spectroscopy Molecules 18, 10802-28
69. Pineda-Lucena, A., Ho, C. S., Mao, D. Y., Sheng, Y., Laister, R. C., Muhandiram, R., Lu, Y., Seet, B. T., Katz, S., Szyperski, T., Penn, L. Z., and Arrowsmith, C. H. (2005) A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants J. Mol. Biol. 351, 182-194
70. Trudeau, T., Nassar, R., Cumberworth, A., Wong, E. T., Woollard, G., and Gsponer, J. (2013) Structure and intrinsic disorder in protein autoinhibition Structure 21, 332-341
71. Benbrook, D. M. and Jones, N. C. (1990) Heterodimer formation between CREB and JUN proteins Oncogene 5, 295-302
72. Song, J. J. and Lee, Y. J. (2003) Role of the ASK1-SEK1-JNK1-HIPK1 signal in Daxx trafficking and ASK1 oligomerization J. Biol. Chem. 278, 47245-47252
73. Vendramini-Costa, D. B. and Carvalho, J. E. (2012) Molecular link mechanisms between inflammation and cancer Curr. Pharm. Des. 18, 3831-3852
74. Sfanos, K. S. and De Marzo, A. M. (2012) Prostate cancer and inflammation: the evidence Histopathology 60, 199-215